|
Drug Monitoring and Toxicology
Citations 461-470 of 565 total displayed.
|
Past content
(since Jan 1997):
|
- TDM Conference
Prospective investigations of concentration–clinical response for immunosuppressive drugs provide the scientific basis for therapeutic drug monitoring
- Leslie M. Shaw, Bruce Kaplan, and Kenneth L. Brayman
Clin. Chem. 1998; 44: 381-387.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Making TDM work to optimize cancer chemotherapy: a multidisciplinary team approach
- Yuen Yi Hon and William E. Evans
Clin. Chem. 1998; 44: 388-400.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Strategies for physician education in therapeutic drug monitoring
- David W. Bates, Steven J. Soldin, Petrie M. Rainey, and Joseph N. Micelli
Clin. Chem. 1998; 44: 401-407.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Clinical outcome and economic impact of aminoglycoside peak concentrations in febrile immunocompromised patients with hematologic malignancies
- Lutz Binder, Xaver Schiel, Claudia Binder, Cristina Fernandes Almeida Menke, Silke Schüttrumpf, Victor W. Armstrong, Michael Unterhalt, Norbert Erichsen, Wolfgang Hiddemann, and Michael Oellerich
Clin. Chem. 1998; 44: 408-414.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Therapeutic drug monitoring in special populations
- Philip D. Walson
Clin. Chem. 1998; 44: 415-419.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Development of new cancer chemoprevention agents: role of pharmacokinetic/pharmacodynamic and intermediate endpoint biomarker monitoring
- Ronald Lieberman, James A. Crowell, Ernest T. Hawk, Charles W. Boone, Caroline C. Sigman, and Gary J. Kelloff
Clin. Chem. 1998; 44: 420-427.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Pharmacodynamic monitoring of immunosuppressive drugs
- Randall W. Yatscoff, Launa J. Aspeslet, and Heather L. Gallant
Clin. Chem. 1998; 44: 428-432.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Supporting pharmaceutical studies for FDA submissions: diversifying the drug monitoring laboratory
- Thomas P. Moyer and Lawrence K. Oliver
Clin. Chem. 1998; 44: 433-436.
[Abstract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Study of arsenic–protein binding in serum of patients on continuous ambulatory peritoneal dialysis
- Xinrong Zhang, Rita Cornelis, Jurgen De Kimpe, Louis Mees, and Norbert Lameire
Clin. Chem. 1998; 44: 141-147.
[Abstract]
[Full text]
[PDF]
- General Clinical Chemistry
Mechanisms of dopamine and dobutamine interference in biochemical tests that use peroxide and peroxidase to generate chromophore
- Brad S. Karon, Thomas M. Daly, and Mitchell G. Scott
Clin. Chem. 1998; 44: 155-160.
[Abstract]
[Full text]
[PDF]
|
|
